Wall Street Journal - May 29
May 29 (Reuters) -The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
- Merck MRK.N is close to a $1.3 billion deal to buy Eyebiotech in cash upfront and make an additional $1.7 billion in milestone payments for the company, which goes by the name EyeBio.
- Activist investor Irenic Capital Management has built a stake of nearly 5% in U.S. trucking company Forward Air FWRD.O. Irenic privately sent a letter to Forward Air's directors this month calling for a board shake-up and a strategic review to consider a range of options including a sale.
- Hess HES.N shareholders on Tuesday voted to approve a $53 billion deal to sell the company to Chevron CVX.N, clearing a hurdle for the companies to combine.
- Adam Neumann has given up on buying WeWork, the bankrupt shared-workspace company he co-founded and was ousted from five years ago and said the company looks to be emerging from bankruptcy with a plan that appears "unrealistic and unlikely to succeed."
- The former chief executive officer of Pioneer Natural Resources, Scott Sheffield, said U.S. antitrust authorities smeared him in their move to block him from joining Exxon Mobil's XOM.N board of directors.
- Chinese firms trying to buffer themselves from Washington's anti-China policies are rebranding and creating U.S.-domiciled businesses to sell their wares as the Biden administration expands the government entity lists that restrict Chinese companies' business dealings in the U.S., say policymakers and national-security experts.
(Compiled by Bengaluru newsroom)
</body></html>
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
